<?xml version="1.0" encoding="UTF-8"?>





<rss xmlns:itunes="http://www.itunes.com/DTDs/Podcast-1.0.dtd" version="2.0">


 





 


	









 








	 	 
<channel>
<title>CROI 2014  - CROI 2014</title>
<itunes:author>CROI</itunes:author>
<description>CROI 2014  - CROI 2014: Themed Discussion Sessions</description>
<itunes:summary>CROI 2014  - CROI 2014: Themed Discussion Sessions</itunes:summary>    
<link>http://www.croiconference.org/</link>
<language>en-us</language>
<copyright>Copyright 2014, CROI. All Rights Reserved.</copyright>
<itunes:category>Podcasts</itunes:category>
 
         
<webMaster>support@capitalreach.com</webMaster>
 
        
  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22084.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Georg M. Lauer of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22084.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22084.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Discussion Leader" by Georg M. Lauer of Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22085.mp3?mediaType=feedmp3</link>
<description>
"Seminal HCV RNA Level May Mirror Dynamics of Plasma HCV RNA in HIV-Positive Men With Acute HCV" by Daniel Bradshaw of Kirby Institute, University of New South Wales, Sydney, Australia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22085.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22085.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Seminal HCV RNA Level May Mirror Dynamics of Plasma HCV RNA in HIV-Positive Men With Acute HCV" by Daniel Bradshaw of Kirby Institute, University of New South Wales, Sydney, Australia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22086.mp3?mediaType=feedmp3</link>
<description>
"Higher Risk of Sexually Acquired HCV Coinfection in MSM With Wide HIV Transmission Bottleneck" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22086.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22086.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Higher Risk of Sexually Acquired HCV Coinfection in MSM With Wide HIV Transmission Bottleneck" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22087.mp3?mediaType=feedmp3</link>
<description>
"Assessing HCV Acquisition Routes in HIV-Infected MSM Using Single Genome Sequencing—A Pilot Study" by Daniel S. Fierer of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22087.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22087.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Assessing HCV Acquisition Routes in HIV-Infected MSM Using Single Genome Sequencing—A Pilot Study" by Daniel S. Fierer of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22088.mp3?mediaType=feedmp3</link>
<description>
"CD3+CD56+ Natural Killer-Like T Cells in HIV(+) Patients With Acute Hepatitis C" by Pavlos Kokordelis of Internal Medicine I, University of Bonn, Bonn, Germany and German Center for Infection Research (DZIF), Bonn, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22088.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22088.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"CD3+CD56+ Natural Killer-Like T Cells in HIV(+) Patients With Acute Hepatitis C" by Pavlos Kokordelis of Internal Medicine I, University of Bonn, Bonn, Germany and German Center for Infection Research (DZIF), Bonn, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Acute HCV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22089.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22089.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22089.mp3</guid>	
 
<itunes:summary>Themed Discussion: Acute HCV Infection

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22090.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Paul W. Spearman of Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22090.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22090.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Discussion Leader" by Paul W. Spearman of Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22091.mp3?mediaType=feedmp3</link>
<description>
"Degradation of SAMHD1 Specifically Decreases the Efficacy of Thymidine HIV RT Analog Inhibitors" by Ester Ballana of IrsiCaixa AIDS Research Institute, Badalona, Spain
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22091.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22091.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Degradation of SAMHD1 Specifically Decreases the Efficacy of Thymidine HIV RT Analog Inhibitors" by Ester Ballana of IrsiCaixa AIDS Research Institute, Badalona, Spain

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22092.mp3?mediaType=feedmp3</link>
<description>
"Characterizing Novel N-Terminal Domains of APOBEC3G" by Meiling R. May of College of the Holy Cross, Worcester, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22092.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22092.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Characterizing Novel N-Terminal Domains of APOBEC3G" by Meiling R. May of College of the Holy Cross, Worcester, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22093.mp3?mediaType=feedmp3</link>
<description>
"Natural Resistance To HIV-1 by Select APOBEC3H Haplotypes" by Eric W. Refsland of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22093.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22093.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Natural Resistance To HIV-1 by Select APOBEC3H Haplotypes" by Eric W. Refsland of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22094.mp3?mediaType=feedmp3</link>
<description>
"Nuclear Import of APOBEC3F-Labeled HIV-1 Preintegration Complexes" by Vinay K. Pathak of HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22094.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22094.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Nuclear Import of APOBEC3F-Labeled HIV-1 Preintegration Complexes" by Vinay K. Pathak of HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Restriction Factors</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22095.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22095.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22095.mp3</guid>	
 
<itunes:summary>Themed Discussion: Restriction Factors

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22096.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Wendy S. Post of The Johns Hopkins University School of Medicine, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22096.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22096.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Discussion Leader" by Wendy S. Post of The Johns Hopkins University School of Medicine, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22097.mp3?mediaType=feedmp3</link>
<description>
"ST2 and GDF-15 Are Associated With Structural Heart Disease and Mortality in HIV" by Eric Secemsky of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22097.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22097.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"ST2 and GDF-15 Are Associated With Structural Heart Disease and Mortality in HIV" by Eric Secemsky of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22098.mp3?mediaType=feedmp3</link>
<description>
"Elevated NT-proBNP Levels Predict Mortality in HIV-Infected Women" by Matthew R. Gingo of University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22098.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22098.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Elevated NT-proBNP Levels Predict Mortality in HIV-Infected Women" by Matthew R. Gingo of University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22099.mp3?mediaType=feedmp3</link>
<description>
"Depression and HIV Are Risk Factors for Incident Heart Failure Among Veterans" by Jessica R. White of University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22099.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22099.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Depression and HIV Are Risk Factors for Incident Heart Failure Among Veterans" by Jessica R. White of University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22100.mp3?mediaType=feedmp3</link>
<description>
"Cardiac Steatosis Increased in HIV: Related To Gender, Visceral Fat and ARV Exposure" by Julia B. Purdy of Critical Care Medicine, National Institutes of Health, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22100.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22100.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Cardiac Steatosis Increased in HIV: Related To Gender, Visceral Fat and ARV Exposure" by Julia B. Purdy of Critical Care Medicine, National Institutes of Health, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22101.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22101.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22101.mp3</guid>	
 
<itunes:summary>Themed Discussion: Heart Failure, Cardiac Steatosis, and HIV

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22102.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Mark F. Cotton of Stellenbosch University, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22102.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22102.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Discussion Leader" by Mark F. Cotton of Stellenbosch University, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22103.mp3?mediaType=feedmp3</link>
<description>
"Routine Antibody Tests Have No Place in Determining HIV Status After Early ART: Evidence From CHER" by Helen Payne of Infectious Diseases and Microbiology, Institute of Child Health, London, United Kingdom and Children’s Infectious Diseases Clinical Research Unit, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22103.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22103.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Routine Antibody Tests Have No Place in Determining HIV Status After Early ART: Evidence From CHER" by Helen Payne of Infectious Diseases and Microbiology, Institute of Child Health, London, United Kingdom and Children’s Infectious Diseases Clinical Research Unit, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22104.mp3?mediaType=feedmp3</link>
<description>
"Different Profiles of HIV in Early Treated HIV-Infected Children Seronegative by ELISA in Cameroon" by Mathurin C. Tejiokem of Service d’Épidémiologie et de Santé Publique, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroon
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22104.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22104.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Different Profiles of HIV in Early Treated HIV-Infected Children Seronegative by ELISA in Cameroon" by Mathurin C. Tejiokem of Service d’Épidémiologie et de Santé Publique, Centre Pasteur du Cameroun, Membre du Réseau International des Instituts Pasteur, Yaoundé, Cameroon

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22105.mp3?mediaType=feedmp3</link>
<description>
"Greater Virologic Control in Infants Initiated On ART Before 6 Months of Age" by Stephanie Shiau of Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22105.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22105.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Greater Virologic Control in Infants Initiated On ART Before 6 Months of Age" by Stephanie Shiau of Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22106.mp3?mediaType=feedmp3</link>
<description>
"Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children" by Claudia S. Crowell of Pediatrics, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22106.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22106.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Early Viral Suppression Improves Neurocognitive Outcomes in HIV-Infected Children" by Claudia S. Crowell of Pediatrics, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22107.mp3?mediaType=feedmp3</link>
<description>
"Early Cytomegalovirus Viraemia and Clinical Outcomes of HIV-Infected Children in the Early ART Era" by Nei-yuan Hsiao of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22107.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22107.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Early Cytomegalovirus Viraemia and Clinical Outcomes of HIV-Infected Children in the Early ART Era" by Nei-yuan Hsiao of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Response to Early ART Initiation in Infants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22108.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22108.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22108.mp3</guid>	
 
<itunes:summary>Themed Discussion: Response to Early ART Initiation in Infants

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22109.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22109.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22109.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Discussion Leader" by David R. Bangsberg of Massachusetts General Hospital Center for Global Health, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22110.mp3?mediaType=feedmp3</link>
<description>
"Comparative Effectiveness of HIV Care and Treatment Programs in East Africa" by Elvin Geng of Medicine, University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22110.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22110.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Comparative Effectiveness of HIV Care and Treatment Programs in East Africa" by Elvin Geng of Medicine, University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22111.mp3?mediaType=feedmp3</link>
<description>
"HIV Care Cascade Among Hard To Reach Populations in India: Need To Expand HIV Counseling and Testing" by Shruti H. Mehta of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22111.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22111.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"HIV Care Cascade Among Hard To Reach Populations in India: Need To Expand HIV Counseling and Testing" by Shruti H. Mehta of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22112.mp3?mediaType=feedmp3</link>
<description>
"Loss To Follow-up: Determining Outcomes for Adults Enrolled in HIV Services in Kenya" by William Reidy of Mailman School of Public Health, ICAP-Columbia University, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22112.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22112.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Loss To Follow-up: Determining Outcomes for Adults Enrolled in HIV Services in Kenya" by William Reidy of Mailman School of Public Health, ICAP-Columbia University, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22113.mp3?mediaType=feedmp3</link>
<description>
"Unplanned Interruptions in HIV Care in Nigeria: Rates and Implications" by Aima A. Ahonkhai of Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22113.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22113.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Unplanned Interruptions in HIV Care in Nigeria: Rates and Implications" by Aima A. Ahonkhai of Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22114.mp3?mediaType=feedmp3</link>
<description>
"Using the Side Door: Non-Linear Patterns Within the HIV Treatment Cascade in Zambia" by Charles B. Holmes of Centre for Infectious Disease Research in Zambia, Lusaka, Zambia and University of North Carolina School of Medicine, Chapel Hill, NC, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22114.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22114.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Using the Side Door: Non-Linear Patterns Within the HIV Treatment Cascade in Zambia" by Charles B. Holmes of Centre for Infectious Disease Research in Zambia, Lusaka, Zambia and University of North Carolina School of Medicine, Chapel Hill, NC, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Treatment Cascade and Loss to Follow-Up</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22115.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22115.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22115.mp3</guid>	
 
<itunes:summary>Themed Discussion: Treatment Cascade and Loss to Follow-Up

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22183.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Susan Cu-Uvin of Brown University, Providence, RI, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22183.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22183.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Discussion Leader" by Susan Cu-Uvin of Brown University, Providence, RI, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22184.mp3?mediaType=feedmp3</link>
<description>
"Depot-Medroxyprogesterone Acetate Does Not Increase Genital SHIV Shedding in Macaques" by Jessica Radzio of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22184.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22184.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Depot-Medroxyprogesterone Acetate Does Not Increase Genital SHIV Shedding in Macaques" by Jessica Radzio of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22185.mp3?mediaType=feedmp3</link>
<description>
"Hormonal Contraceptives Increase Innate Immune Effector Molecules in Cervicovaginal Secretions" by Alison Roxby of Department of Global Health, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22185.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22185.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Hormonal Contraceptives Increase Innate Immune Effector Molecules in Cervicovaginal Secretions" by Alison Roxby of Department of Global Health, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22186.mp3?mediaType=feedmp3</link>
<description>
"Injectable Contraception and HIV Acquisition in the VOICE Study (MTN-003)" by Lisa M. Noguchi of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States and Microbicide Trials Network, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22186.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22186.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Injectable Contraception and HIV Acquisition in the VOICE Study (MTN-003)" by Lisa M. Noguchi of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States and Microbicide Trials Network, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22187.mp3?mediaType=feedmp3</link>
<description>
"Dysregulation of Estradiol Signaling Contributes To Mucosal Barrier Dysfunction HIV+ Women" by Sumathi Sankaran-Walters of Medical Microbiology and Immunology, University of CA, Davis, Davis, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22187.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22187.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Dysregulation of Estradiol Signaling Contributes To Mucosal Barrier Dysfunction HIV+ Women" by Sumathi Sankaran-Walters of Medical Microbiology and Immunology, University of CA, Davis, Davis, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22188.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22188.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22188.mp3</guid>	
 
<itunes:summary>Themed Discussion: Reproductive Hormones in Women: Impact on Risk and Barrier Dysfunction

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22189.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Marion G. Peters of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22189.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22189.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Discussion Leader" by Marion G. Peters of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22190.mp3?mediaType=feedmp3</link>
<description>
"Telaprevir in Treatment-Experienced HIV-HCV G1 Coinfected Patients (ANRS HC26 TelapreVIH)" by Laurent Cotte of Infectious Diseases, Hospices Civils de Lyon, Lyon, France and U1052, INSERM, Lyon, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22190.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22190.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Telaprevir in Treatment-Experienced HIV-HCV G1 Coinfected Patients (ANRS HC26 TelapreVIH)" by Laurent Cotte of Infectious Diseases, Hospices Civils de Lyon, Lyon, France and U1052, INSERM, Lyon, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22191.mp3?mediaType=feedmp3</link>
<description>
"Boceprevir/Telaprevir-Based Therapy in HIV-Infection: Interim Analysis of a Multicenter Cohort" by Karin Neukam of Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain and University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22191.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22191.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Boceprevir/Telaprevir-Based Therapy in HIV-Infection: Interim Analysis of a Multicenter Cohort" by Karin Neukam of Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain and University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22192.mp3?mediaType=feedmp3</link>
<description>
"Protease Inhibitors To Treat Hepatitis C in the Swiss HIV Cohort Study: High Efficacy But Low Uptake" by Sebastian Haubitz of Division of Infectious Diseases, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22192.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22192.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Protease Inhibitors To Treat Hepatitis C in the Swiss HIV Cohort Study: High Efficacy But Low Uptake" by Sebastian Haubitz of Division of Infectious Diseases, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22193.mp3?mediaType=feedmp3</link>
<description>
"Slow HCV-RNA Decay and Early Resistance Predict the Risk of Failure To TVR/BOC Treatment" by Francesca Ceccherini-Silberstein of Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22193.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22193.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Slow HCV-RNA Decay and Early Resistance Predict the Risk of Failure To TVR/BOC Treatment" by Francesca Ceccherini-Silberstein of Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22194.mp3?mediaType=feedmp3</link>
<description>
"Favorable Adverse Event Profile of Sofosbuvir/Ribavirin Versus Standard of Care for Hepatitis C" by Kerry Townsend of LIR, NIAID, NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22194.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22194.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Favorable Adverse Event Profile of Sofosbuvir/Ribavirin Versus Standard of Care for Hepatitis C" by Kerry Townsend of LIR, NIAID, NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22195.mp3?mediaType=feedmp3</link>
<description>
"Sustained Virologic Response and the Risk of Liver Decompensation in HCV and HIV/HCV Patients" by Temitope O. Olufade of US Outcomes Research, Merck Sharpe &amp; Dohme, North Wales, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22195.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22195.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Sustained Virologic Response and the Risk of Liver Decompensation in HCV and HIV/HCV Patients" by Temitope O. Olufade of US Outcomes Research, Merck Sharpe &amp; Dohme, North Wales, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22196.mp3?mediaType=feedmp3</link>
<description>
"Predicting Risk of ESLD in HIV/HCV Patients for Individualized HCV Therapy Decisions" by Vincent Lo Re of University of Pennsylvania, Philadelphia, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22196.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22196.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Predicting Risk of ESLD in HIV/HCV Patients for Individualized HCV Therapy Decisions" by Vincent Lo Re of University of Pennsylvania, Philadelphia, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Real-World Experiences with Hepatitis C</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22197.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22197.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22197.mp3</guid>	
 
<itunes:summary>Themed Discussion: Real-World Experiences with Hepatitis C

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22198.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Kevin E. Yarasheski of Washington University School of Medicine, St Louis, MO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22198.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22198.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Discussion Leader" by Kevin E. Yarasheski of Washington University School of Medicine, St Louis, MO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22199.mp3?mediaType=feedmp3</link>
<description>
"Geriatric Syndromes Are Common Among Older HIV-Infected Adults" by Meredith Greene of Medicine-Geriatrics, University of California San Francisco, San Francisco, CA, United States and San Francisco VA Medical Center, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22199.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22199.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Geriatric Syndromes Are Common Among Older HIV-Infected Adults" by Meredith Greene of Medicine-Geriatrics, University of California San Francisco, San Francisco, CA, United States and San Francisco VA Medical Center, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22200.mp3?mediaType=feedmp3</link>
<description>
"Physical Function Impairment On Quality of Life Among Persons Aging With HIV Infection" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22200.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22200.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Physical Function Impairment On Quality of Life Among Persons Aging With HIV Infection" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22201.mp3?mediaType=feedmp3</link>
<description>
"Cell-Mediated CMV Responses in HIV-Infected Persons With Impaired Physical Function" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22201.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22201.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Cell-Mediated CMV Responses in HIV-Infected Persons With Impaired Physical Function" by Kristine M. Erlandson of University of Colorado Anschutz Medical Campus, Aurora, CO, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22202.mp3?mediaType=feedmp3</link>
<description>
"Frailty, Inflammation and Mortality Among Aging HIV-Infected and At-Risk Injection Drug Users" by Damani A. Piggott of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22202.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22202.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Frailty, Inflammation and Mortality Among Aging HIV-Infected and At-Risk Injection Drug Users" by Damani A. Piggott of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22203.mp3?mediaType=feedmp3</link>
<description>
"Brisk Walking Improves Inflammatory Markers in cART-Treated Patients" by Valeria Longo of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22203.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22203.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Brisk Walking Improves Inflammatory Markers in cART-Treated Patients" by Valeria Longo of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Frailty and Functional Impairment</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22204.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22204.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22204.mp3</guid>	
 
<itunes:summary>Themed Discussion: Frailty and Functional Impairment

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22205.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Stephen Taylor of Birmingham Heartlands Hospital, Birmingham, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22205.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22205.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Discussion Leader" by Stephen Taylor of Birmingham Heartlands Hospital, Birmingham, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22206.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetics of Raltegravir 400 vs 800 mg BID With Intermittent Rifampicin Dosed Thrice Weekly" by Saye H. Khoo of University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22206.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22206.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Pharmacokinetics of Raltegravir 400 vs 800 mg BID With Intermittent Rifampicin Dosed Thrice Weekly" by Saye H. Khoo of University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22207.mp3?mediaType=feedmp3</link>
<description>
"Relationship Between Efavirenz Trough &amp; CYP2B6 Genotypes With Rifampin-Based TB Therapy in STRIDE" by Anne Luetkemeyer of HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22207.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22207.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Relationship Between Efavirenz Trough &amp; CYP2B6 Genotypes With Rifampin-Based TB Therapy in STRIDE" by Anne Luetkemeyer of HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22208.mp3?mediaType=feedmp3</link>
<description>
"Pharmacokinetics of Faldaprevir and Antiretrovirals in Patients With HIV/HCV Coinfection" by Jürgen K. K. Rockstroh of Department of Medicine I, University of Bonn, Bonn, Germany
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22208.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22208.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Pharmacokinetics of Faldaprevir and Antiretrovirals in Patients With HIV/HCV Coinfection" by Jürgen K. K. Rockstroh of Department of Medicine I, University of Bonn, Bonn, Germany

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22209.mp3?mediaType=feedmp3</link>
<description>
"Relative Genetic Contribution To the Pharmacokinetics of Commonly Prescribed Antiretrovirals" by Marco S. Siccardi of Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22209.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22209.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Relative Genetic Contribution To the Pharmacokinetics of Commonly Prescribed Antiretrovirals" by Marco S. Siccardi of Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22210.mp3?mediaType=feedmp3</link>
<description>
"Leveraging Genomics in HIV Treatment Decisions" by Paul J. McLaren of The Swiss HIV Cohort, Lausanne, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22210.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22210.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Leveraging Genomics in HIV Treatment Decisions" by Paul J. McLaren of The Swiss HIV Cohort, Lausanne, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Clinical Pharmacology in Patient Care</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22211.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22211.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22211.mp3</guid>	
 
<itunes:summary>Themed Discussion: Clinical Pharmacology in Patient Care

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22212.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22212.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22212.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Discussion Leader" by Roger D. Kouyos of University Hospital Zurich, University of Zurich, Zurich, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22213.mp3?mediaType=feedmp3</link>
<description>
"HIV Transmission in the United States: The Roles of Risk Group, Race/Ethnicity, and Geography" by Alexandra M. Oster of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22213.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22213.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"HIV Transmission in the United States: The Roles of Risk Group, Race/Ethnicity, and Geography" by Alexandra M. Oster of Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22214.mp3?mediaType=feedmp3</link>
<description>
"Ongoing HIV-1 Subtype B Transmission Networks in the Netherlands" by Daniela Bezemer of Research, HIV Monitoring Foundation, Amsterdam, Netherlands
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22214.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22214.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Ongoing HIV-1 Subtype B Transmission Networks in the Netherlands" by Daniela Bezemer of Research, HIV Monitoring Foundation, Amsterdam, Netherlands

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22215.mp3?mediaType=feedmp3</link>
<description>
"Using HIV Networks To Inform Real Time Prevention Interventions" by Susan J. Little of Medicine, University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22215.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22215.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Using HIV Networks To Inform Real Time Prevention Interventions" by Susan J. Little of Medicine, University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22216.mp3?mediaType=feedmp3</link>
<description>
"Large MSM Group and Local Heterosexual Transmission Are Major Concerns in the HIV Epidemic in Japan" by Teiichiro Shiino of Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22216.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22216.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Large MSM Group and Local Heterosexual Transmission Are Major Concerns in the HIV Epidemic in Japan" by Teiichiro Shiino of Infectious Diseases Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22217.mp3?mediaType=feedmp3</link>
<description>
"Transmission Networks of HIV-1 Subtype B, CRF01_AE and CRF51_01B Among MSM in Singapore" by Kim Tien Ng of Centre of Excellence for Research in AIDS (CERiA), Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22217.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22217.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Transmission Networks of HIV-1 Subtype B, CRF01_AE and CRF51_01B Among MSM in Singapore" by Kim Tien Ng of Centre of Excellence for Research in AIDS (CERiA), Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22218.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 Phylodynamics and Phylogeography Among High-Risk and General Populations in Uganda" by Gonzalo Yebra of Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22218.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22218.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"HIV-1 Phylodynamics and Phylogeography Among High-Risk and General Populations in Uganda" by Gonzalo Yebra of Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: How Transmission Networks Drive Epidemics</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22219.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22219.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22219.mp3</guid>	
 
<itunes:summary>Themed Discussion: How Transmission Networks Drive Epidemics

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22220.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Peter W. Hunt of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22220.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22220.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Discussion Leader" by Peter W. Hunt of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22221.mp3?mediaType=feedmp3</link>
<description>
"Rapid Gut-Homing of Plasmacytoid Dendritic Cells During Acute SIV Infection" by R. Keith Reeves of NEPRC, Harvard Medical School, Southborough, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22221.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22221.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Rapid Gut-Homing of Plasmacytoid Dendritic Cells During Acute SIV Infection" by R. Keith Reeves of NEPRC, Harvard Medical School, Southborough, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22222.mp3?mediaType=feedmp3</link>
<description>
"CCR6+ and CD161+ CD4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques" by Colleen S. McGary of Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22222.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22222.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"CCR6+ and CD161+ CD4 T Cell Loss Contributes To the Pathogenesis of SIV Infection in Rhesus Macaques" by Colleen S. McGary of Department of Microbiology and Immunology, Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22223.mp3?mediaType=feedmp3</link>
<description>
"Decreased Diversity of Gut Microbiota Is Associated With Immune Status During HIV-1 Infection" by Babilonia Barqasho of Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22223.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22223.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Decreased Diversity of Gut Microbiota Is Associated With Immune Status During HIV-1 Infection" by Babilonia Barqasho of Department of Laboratory Medicine, Karolinska Institute, Huddinge, Sweden

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22224.mp3?mediaType=feedmp3</link>
<description>
"Dysbiotic Bacteria Translocate in Progressive SIV Infection" by Zachary Klase of Laboratory of Molecular Microbiology, NIAID/NIH, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22224.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22224.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Dysbiotic Bacteria Translocate in Progressive SIV Infection" by Zachary Klase of Laboratory of Molecular Microbiology, NIAID/NIH, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22225.mp3?mediaType=feedmp3</link>
<description>
"Breaches in Colonic Claudin-4 Expression Correlate With T-Cell Activation in HIV-1 Infection" by Louise Greathead of Imperial College, London, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22225.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22225.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Breaches in Colonic Claudin-4 Expression Correlate With T-Cell Activation in HIV-1 Infection" by Louise Greathead of Imperial College, London, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22226.mp3?mediaType=feedmp3</link>
<description>
"Increased Immune Activation After Gut Permeabilization in SIV-Infected African Green Monkeys" by Jan Kristoff of Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22226.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22226.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Increased Immune Activation After Gut Permeabilization in SIV-Infected African Green Monkeys" by Jan Kristoff of Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Gut and Immune Activation</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22227.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22227.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22227.mp3</guid>	
 
<itunes:summary>Themed Discussion: Gut and Immune Activation

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22307.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Thomas S. Uldrick of National Cancer Institute, Bethesda, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22307.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22307.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Discussion Leader" by Thomas S. Uldrick of National Cancer Institute, Bethesda, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22308.mp3?mediaType=feedmp3</link>
<description>
"Guidelines On Kaposi’s Sarcoma Treatment: Results From Two Cochrane Systematic Reviews" by Esther E. Freeman of Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22308.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22308.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Guidelines On Kaposi’s Sarcoma Treatment: Results From Two Cochrane Systematic Reviews" by Esther E. Freeman of Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22309.mp3?mediaType=feedmp3</link>
<description>
"Kaposi Sarcoma in the Era of Combination Antiretroviral Therapy" by Matthias Egger of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22309.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22309.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Kaposi Sarcoma in the Era of Combination Antiretroviral Therapy" by Matthias Egger of Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22310.mp3?mediaType=feedmp3</link>
<description>
"Randomized Trial of Protease Inhibitor-Based Antiretroviral Therapy for Kaposi Sarcoma in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22310.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22310.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Randomized Trial of Protease Inhibitor-Based Antiretroviral Therapy for Kaposi Sarcoma in Africa" by Jeffrey Martin of University of California San Francisco, San Francisco, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22311.mp3?mediaType=feedmp3</link>
<description>
"The Effect of Protease Inhibitor Use On Kaposi Sarcoma Incidence in a cART-Experienced Cohort" by Elizabeth Chiao of Baylor College of Medicine, Houston, TX, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22311.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22311.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"The Effect of Protease Inhibitor Use On Kaposi Sarcoma Incidence in a cART-Experienced Cohort" by Elizabeth Chiao of Baylor College of Medicine, Houston, TX, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22312.mp3?mediaType=feedmp3</link>
<description>
"Indoleamine 2,3-Dioxygenase (IDO) Activity as a Determinant of Kaposi Sarcoma in Africa" by Helen Byakwaga of University of California San Francisco, San Francisco, CA, United States and Mbarara University of Science and Technology, Mbarara, Uganda
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22312.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22312.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Indoleamine 2,3-Dioxygenase (IDO) Activity as a Determinant of Kaposi Sarcoma in Africa" by Helen Byakwaga of University of California San Francisco, San Francisco, CA, United States and Mbarara University of Science and Technology, Mbarara, Uganda

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Kaposi Sarcoma</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22313.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22313.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22313.mp3</guid>	
 
<itunes:summary>Themed Discussion: Kaposi Sarcoma

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22314.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Marshall J. Glesby of Weill Cornell Medical College, New York, NY, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22314.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22314.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Discussion Leader" by Marshall J. Glesby of Weill Cornell Medical College, New York, NY, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22315.mp3?mediaType=feedmp3</link>
<description>
"HIV Infection and Related Biomarkers Are Independent Risk Factors for Radiographic Emphysema" by Engi F. Attia of Medicine, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22315.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22315.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"HIV Infection and Related Biomarkers Are Independent Risk Factors for Radiographic Emphysema" by Engi F. Attia of Medicine, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22316.mp3?mediaType=feedmp3</link>
<description>
"Factors Associated With Chronic Obstructive Pulmonary Disease in a High-Risk HIV-Infected Cohort" by Alain Makinson of Infectious and Tropical Diseases Department, University Hospital Montpellier 1, UMI 233, Montpellier, France
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22316.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22316.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Factors Associated With Chronic Obstructive Pulmonary Disease in a High-Risk HIV-Infected Cohort" by Alain Makinson of Infectious and Tropical Diseases Department, University Hospital Montpellier 1, UMI 233, Montpellier, France

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22317.mp3?mediaType=feedmp3</link>
<description>
"HIV Infection Increases Risk of Acute Exacerbations of COPD" by Allison A. Lambert of The Johns Hopkins University, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22317.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22317.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"HIV Infection Increases Risk of Acute Exacerbations of COPD" by Allison A. Lambert of The Johns Hopkins University, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22318.mp3?mediaType=feedmp3</link>
<description>
"Association of HIV Infection and Immune Activation With Decline in Lung Function" by Kristina Crothers of Department of Medicine, University of Washington, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22318.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22318.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Association of HIV Infection and Immune Activation With Decline in Lung Function" by Kristina Crothers of Department of Medicine, University of Washington, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Pulmonary Complications of HIV Infection</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22319.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22319.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22319.mp3</guid>	
 
<itunes:summary>Themed Discussion: Pulmonary Complications of HIV Infection

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22320.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Christine M. Rousseau of Bill and Melinda Gates Foundation, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22320.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22320.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Discussion Leader" by Christine M. Rousseau of Bill and Melinda Gates Foundation, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22321.mp3?mediaType=feedmp3</link>
<description>
"Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens" by Erin K. Rottinghaus of Centers for Disease Control and Prevention, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22321.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22321.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens" by Erin K. Rottinghaus of Centers for Disease Control and Prevention, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22322.mp3?mediaType=feedmp3</link>
<description>
"Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US" by Andrew F. Longosz of Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22322.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22322.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US" by Andrew F. Longosz of Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22323.mp3?mediaType=feedmp3</link>
<description>
"The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda" by Andrew F. Longosz of NIAID, National Insitutes of Health, Baltimore, MD, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22323.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22323.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda" by Andrew F. Longosz of NIAID, National Insitutes of Health, Baltimore, MD, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22324.mp3?mediaType=feedmp3</link>
<description>
"Independent Evaluation of Predicate Incidence Assays for HIV Surveillance" by Alex Welte of The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22324.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22324.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Independent Evaluation of Predicate Incidence Assays for HIV Surveillance" by Alex Welte of The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: Incidence Assays</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22325.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22325.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22325.mp3</guid>	
 
<itunes:summary>Themed Discussion: Incidence Assays

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22326.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Paula M. Cannon of University of Southern California, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22326.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22326.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Discussion Leader" by Paula M. Cannon of University of Southern California, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22327.mp3?mediaType=feedmp3</link>
<description>
"Impact of Systemic Cytotoxic Chemotherapy for Malignancies On HIV-1 Reservoir Persistence" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22327.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22327.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Impact of Systemic Cytotoxic Chemotherapy for Malignancies On HIV-1 Reservoir Persistence" by Timothy J. Henrich of Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22328.mp3?mediaType=feedmp3</link>
<description>
"Dynamics of HSPC Repopulation in Nonhuman Primates Revealed by a Decade-Long Clonal Tracking" by Sanggu Kim of University of California, Los Angeles, Los Angeles, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22328.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22328.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Dynamics of HSPC Repopulation in Nonhuman Primates Revealed by a Decade-Long Clonal Tracking" by Sanggu Kim of University of California, Los Angeles, Los Angeles, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22329.mp3?mediaType=feedmp3</link>
<description>
"Targeting SIV Reservoirs via Autologous Hematopoietic Stem Cell Transplant in Rhesus Macaques" by Maud Mavigner of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22329.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22329.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Targeting SIV Reservoirs via Autologous Hematopoietic Stem Cell Transplant in Rhesus Macaques" by Maud Mavigner of Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22330.mp3?mediaType=feedmp3</link>
<description>
"Modeling Functional Cure of HIV in Nonhuman Primates Using Gene-Modified Hematopoietic Stem Cells" by Hans-Peter Kiem of Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22330.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22330.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Modeling Functional Cure of HIV in Nonhuman Primates Using Gene-Modified Hematopoietic Stem Cells" by Hans-Peter Kiem of Transplantation Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: What We Learn From Bone Marrow Transplants</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22331.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22331.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22331.mp3</guid>	
 
<itunes:summary>Themed Discussion: What We Learn From Bone Marrow Transplants

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22333.mp3?mediaType=feedmp3</link>
<description>
"Discussion Leader" by Scott L. Letendre of University of California San Diego, San Diego, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22333.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22333.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Discussion Leader" by Scott L. Letendre of University of California San Diego, San Diego, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22334.mp3?mediaType=feedmp3</link>
<description>
"CNS Outcomes of cART vs. cART plus Maraviroc and Raltegravir Intensification During Acute HIV" by James L. K. Fletcher of SEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22334.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22334.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"CNS Outcomes of cART vs. cART plus Maraviroc and Raltegravir Intensification During Acute HIV" by James L. K. Fletcher of SEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22335.mp3?mediaType=feedmp3</link>
<description>
"HIV-1 RNA Detection in CSF in ART-Treated Subjects With Incomplete Viral Suppression in Plasma" by Sam Nightingale of Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22335.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22335.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"HIV-1 RNA Detection in CSF in ART-Treated Subjects With Incomplete Viral Suppression in Plasma" by Sam Nightingale of Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22336.mp3?mediaType=feedmp3</link>
<description>
"CSF Viral Escape in Patients Without Neurological Disorders: Prevalence and Associated Factors" by Carmela Pinnetti of National Institute for Infectious Disease, Rome, Italy
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22336.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22336.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"CSF Viral Escape in Patients Without Neurological Disorders: Prevalence and Associated Factors" by Carmela Pinnetti of National Institute for Infectious Disease, Rome, Italy

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22337.mp3?mediaType=feedmp3</link>
<description>
"Cerebrospinal Fluid Viral Blips and Persistent Escape in HIV-Infected Patients On ART" by Arvid Eden of University of Gothenburg, Gothenburg, Sweden
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22337.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22337.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Cerebrospinal Fluid Viral Blips and Persistent Escape in HIV-Infected Patients On ART" by Arvid Eden of University of Gothenburg, Gothenburg, Sweden

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22338.mp3?mediaType=feedmp3</link>
<description>
"Mitochondrial DNA Is Associated With Inflammation and Neurocognitive Deficits in HIV Infection" by Josué Pérez-Santiago of Medicine, University of California San Diego, La Jolla, CA, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22338.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22338.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Mitochondrial DNA Is Associated With Inflammation and Neurocognitive Deficits in HIV Infection" by Josué Pérez-Santiago of Medicine, University of California San Diego, La Jolla, CA, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22339.mp3?mediaType=feedmp3</link>
<description>
"Early Monocyte Inflammation Among Treatment-Naïve Acute HIV-Infected Thai Subjects" by Lishomwa C. Ndhlovu of Hawaii Center for AIDS, University of Hawaii, Honolulu, HI, United States
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22339.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22339.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Early Monocyte Inflammation Among Treatment-Naïve Acute HIV-Infected Thai Subjects" by Lishomwa C. Ndhlovu of Hawaii Center for AIDS, University of Hawaii, Honolulu, HI, United States

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


  
 


	    

 		
 		 
 		 
		 	
			 
			  
			 
			 	 
			 
	   		 
					
		 
		
		

	 


 


	
















	



	


 
	
 
	 

 
	 

 
 

 


	





	





	 

 























>







 				 
<item>
<title>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART</title>
<itunes:author>CROI</itunes:author>
<link>http://www.croiwebcasts.org/console/player/22340.mp3?mediaType=feedmp3</link>
<description>
"Questions and Answers" by  of 
</description>
<enclosure url="http://www.croiwebcasts.org/console/player/22340.mp3?mediaType=feedmp3"  type="audio/mpeg"/>
 
<guid>http://www.croiwebcasts.org/console/player/22340.mp3</guid>	
 
<itunes:summary>Themed Discussion: CNS Viral Escape and Neuroinflammation on ART

"Questions and Answers" by  of 

</itunes:summary>
 
 
 
 
 
 
 
 
 
 

 
 
 
	 
	 
	
		
		
		
			 
	
	
	
	
	
	



<itunes:duration>00:00:00.0</itunes:duration> 
<itunes:category>Podcasts</itunes:category>
<category>Podcasts</category>

<pubDate></pubDate>
</item>


	
 
</channel>
</rss>
